tiprankstipranks
Trending News
More News >
OncoSil Medical Ltd (AU:OSL)
ASX:OSL
Australian Market

OncoSil Medical Ltd (OSL) Ratios

Compare
18 Followers

OncoSil Medical Ltd Ratios

AU:OSL's free cash flow for Q4 2025 was AU$-1.31. For the 2025 fiscal year, AU:OSL's free cash flow was decreased by AU$ and operating cash flow was AU$-15.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.67 1.67 3.26 7.16 7.21
Quick Ratio
1.67 1.67 3.19 7.16 7.21
Cash Ratio
1.27 1.27 2.32 5.99 6.38
Solvency Ratio
-3.73 -3.72 -5.99 -7.01 -5.56
Operating Cash Flow Ratio
-2.99 -2.99 -5.57 -7.21 -5.72
Short-Term Operating Cash Flow Coverage
-224.67 -224.67 -335.97 -77.37 -61.13
Net Current Asset Value
AU$ 2.68MAU$ 2.68MAU$ 4.35MAU$ 9.64MAU$ 10.84M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.01 0.01 0.02
Debt-to-Equity Ratio
0.02 0.02 0.01 0.02 0.03
Debt-to-Capital Ratio
0.02 0.02 0.01 0.02 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
2.30 2.30 1.42 1.16 1.17
Debt Service Coverage Ratio
-269.59 -276.84 -328.13 -64.06 -57.17
Interest Coverage Ratio
-17.20K -21.45K -3.31K -1.15K -581.40
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
0.33 0.33 0.34 0.83 0.96
Profitability Margins
Gross Profit Margin
-402.21%-92.49%-192.21%-332.08%-2902.18%
EBIT Margin
-1495.19%-1289.65%-2319.64%-3082.87%-4978.23%
EBITDA Margin
-1493.86%-1286.60%-2499.74%-3037.18%-4922.15%
Operating Profit Margin
-1495.19%-1322.94%-2522.68%-3414.28%-4922.29%
Pretax Profit Margin
-1548.44%-1289.71%-2509.02%-3384.22%-4986.43%
Net Profit Margin
-1496.31%-1289.71%-2306.09%-3085.04%-4627.92%
Continuous Operations Profit Margin
-1512.33%-1289.71%-2306.09%-3085.04%-4627.92%
Net Income Per EBT
96.63%100.00%91.91%91.16%92.81%
EBT Per EBIT
103.56%97.49%99.46%99.12%101.30%
Return on Assets (ROA)
-211.24%-211.24%-177.33%-98.86%-82.08%
Return on Equity (ROE)
-258.93%-486.54%-251.54%-114.80%-96.10%
Return on Capital Employed (ROCE)
-483.65%-496.48%-272.95%-126.74%-100.95%
Return on Invested Capital (ROIC)
-456.66%-479.96%-247.53%-112.22%-91.02%
Return on Tangible Assets
-211.24%-211.24%-177.33%-98.86%-82.08%
Earnings Yield
-178.44%-115.14%-0.27%-0.21%-0.08%
Efficiency Ratios
Receivables Turnover
0.84 0.97 0.42 0.29 0.26
Payables Turnover
1.18 1.18 1.34 1.65 1.04
Inventory Turnover
0.00 0.00 12.40 0.00 0.00
Fixed Asset Turnover
2.38 2.76 1.33 1.54 0.71
Asset Turnover
0.14 0.16 0.08 0.03 0.02
Working Capital Turnover Ratio
0.19 0.33 0.07 0.04 0.02
Cash Conversion Cycle
125.44 65.29 633.84 1.06K 1.08K
Days of Sales Outstanding
435.67 375.52 875.96 1.28K 1.43K
Days of Inventory Outstanding
0.00 0.00 29.44 0.00 0.00
Days of Payables Outstanding
310.22 310.22 271.56 220.59 349.45
Operating Cycle
435.67 375.52 905.40 1.28K 1.43K
Cash Flow Ratios
Operating Cash Flow Per Share
-1.01 -1.10 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
-1.01 -1.11 >-0.01 >-0.01 >-0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.02 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
-806.09 -806.09 -54.93 -195.71 -1.73K
Capital Expenditure Coverage Ratio
-806.09 -806.09 -54.93 -195.71 -1.73K
Operating Cash Flow Coverage Ratio
-172.53 -172.53 -153.16 -66.25 -33.23
Operating Cash Flow to Sales Ratio
-11.95 -10.30 -20.95 -30.78 -43.62
Free Cash Flow Yield
-90.04%-92.09%-0.25%-0.21%-0.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.57 -0.87 -372.57 -477.66 -1.21K
Price-to-Sales (P/S) Ratio
13.48 11.20 8.59K 14.74K 55.98K
Price-to-Book (P/B) Ratio
2.77 4.23 937.16 548.36 1.16K
Price-to-Free Cash Flow (P/FCF) Ratio
-1.13 -1.09 -402.74 -476.38 -1.28K
Price-to-Operating Cash Flow Ratio
-0.71 -1.09 -410.07 -478.81 -1.28K
Price-to-Earnings Growth (PEG) Ratio
<0.01 >-0.01 8.76 68.92 -293.31
Price-to-Fair Value
2.77 4.23 937.16 548.36 1.16K
Enterprise Value Multiple
-0.57 -0.54 -343.36 -484.36 -1.14K
Enterprise Value
8.37M 8.07M 4.43B 5.41B 12.96B
EV to EBITDA
-0.56 -0.54 -343.36 -484.36 -1.14K
EV to Sales
8.30 6.90 8.58K 14.71K 55.93K
EV to Free Cash Flow
-0.69 -0.67 -402.34 -475.57 -1.28K
EV to Operating Cash Flow
-0.69 -0.67 -409.67 -478.00 -1.28K
Tangible Book Value Per Share
0.26 0.28 <0.01 <0.01 0.01
Shareholders’ Equity Per Share
0.26 0.28 <0.01 <0.01 0.01
Tax and Other Ratios
Effective Tax Rate
0.02 0.00 0.08 0.09 0.07
Revenue Per Share
0.08 0.11 <0.01 <0.01 <0.01
Net Income Per Share
-1.27 -1.38 >-0.01 >-0.01 -0.01
Tax Burden
0.97 1.00 0.92 0.91 0.93
Interest Burden
1.04 1.00 1.08 1.10 1.00
Research & Development to Revenue
4.17 3.60 5.79 7.75 10.25
SG&A to Revenue
4.23 6.44 12.45 17.84 29.34
Stock-Based Compensation to Revenue
0.67 0.00 1.19 1.05 2.56
Income Quality
0.80 0.00 0.91 1.00 0.94
Currency in AUD